JONBUR Research
Reports on Korean companies, written by AI from filed financial statements, market data and news: a full report when we start covering a company, then short update notes after big events like results, deals or new shares.
This is not financial advice. The report does not recommend buying or selling anything.
Featured
Most viewed
- 1SK hynixSK hynix: Model fair value estimate rises 60% to ₩872,969 base2
- 2Samsung Electro-MechanicsSamsung Electro-Mechanics: Model Fair Value Estimate Cut 40% to ₩84,134 Per Share1
- 3Samyang HoldingsSamyang Holdings: Thin Operating Profit, Net Losses and a Deep Discount to Book Value0
- 4Hite JinroHite Jinro: Thin Profit Margins and a Model Estimate Near the Share Price0
- 5Hite JinroHite Jinro: Model Fair Value Estimate Rises 70% as Discount Rate Falls to 6.0%0
- 6YuhanYuhan: Profits Recover From a Low Base as the Shares Fall 40.3% Over One Year0
- 7YuhanYuhan Shares Rise 21.4% in Five Trading Days on Heavy Volume0
- 8CJ LogisticsCJ Logistics: Shares Near 52-Week Low While Earnings Stay Steady and Multiples Sit Below Peers0
- 9DoosanDoosan: Profits Recovering From Losses, Shares Up Sharply Over a Year but Down Last Month0
- 10DL HoldingsDL Holdings: Share Price Down 18.6% in a Month as Earnings Recover but Net Margin Stays Thin0
All reports
Kinx093320· InternetInitiation
Kinx: Steady Revenue Growth and Margin Recovery, but Shares Trade Above a Model Estimate
Kinx, a KOSDAQ-listed internet company, has grown revenue every year since 2021, and its trailing operating margin has recovered to 18.6% from 15.0% in 2025. The share price of ₩125,200 sits above the valuation model's base estimate of ₩97,511 per share, after a 12.6% fall over three months.
Oct 27, 20260 views
Orion271560· Food & BeverageUpdate note
Orion: Model Fair Value Estimate Rises 21% on Lower Discount Rate
Our model estimate of Orion's fair value rose to ₩235,558 per share in the base case from ₩190,469, a 21.0% increase. The change comes from updated model assumptions, not from new filings, and it does not alter the operating picture described in the previous report.
Oct 27, 20260 views
Jeio418550· Engineering servicesInitiation
Jeio: Revenue Decline and Operating Losses Continue as Shares Trade Below Book Value
Jeio, a KOSDAQ-listed engineering services company, closed at ₩4,185 on 2026-10-26, down 55.0% over one year and 12.9% over the past month. Filed figures show revenue falling since 2023 and operating losses in the trailing twelve months, while the price-to-book ratio is 0.8.
Oct 27, 20260 views
Medy-Tox086900· Biotech & PharmaUpdate note
Medy-Tox: Model Fair Value Estimate Cut by About a Third to ₩34,974 Base Case
Our model estimate of Medy-Tox's fair value fell sharply, with the base case now at ₩34,974 per share versus ₩51,161 in the previous report. The share price of ₩66,200 remains well above the base case, so the gap between model and market has widened.
Oct 27, 20260 views
Msdi123010· Electronic componentsInitiation
Msdi: Operating Profit Returns While Net Loss Persists and Capital Raising Filings Pile Up
Msdi, a KOSDAQ electronic components company, reports trailing operating income of ₩3.7B on revenue of ₩38.0B, but net income is still slightly negative at -₩236.7M. Recent filings show repeated amendments to a rights offering and a convertible bond, and the share price is up 45.1% over one year.
Oct 27, 20260 views
Unid014830· ChemicalsInitiation
Unid: Shares Near 52-Week Low as Earnings Soften and Q3 Posts an Operating Loss
Unid's shares closed at ₩51,300 on 2026-10-26, down 31.6% over one year and close to the 52-week low of ₩50,900. Trailing earnings remain profitable, but a Q3 operating loss of ₩2.1B was reported and a model estimate sits well above the share price.
Oct 27, 20260 views
Samsung Biologics207940· Biotech & PharmaUpdate note
Model Fair Value Estimate for Samsung Biologics Rises 22.9% to ₩580,299 Base Case
Our model estimate of fair value for Samsung Biologics moved up to a base case of ₩580,299 per share, from ₩472,202 in the previous report. The share price of ₩1,452,000 remains far above even the new bull case, so the change does not alter the gap between the model and the market.
Oct 27, 20260 views
NAVER035420· InternetUpdate note
NAVER: Headline reports a ₩9T AI infrastructure contract and a Brookfield subsidiary link, but details are unconfirmed
A news headline says NAVER signed a ₩9T (about $9B) AI infrastructure contract and became a subsidiary of a Brookfield investment vehicle. The filings provided give no details, so the effect on the company's finances and ownership cannot yet be measured.
Oct 27, 20260 views
Hanmi Pharm128940· Biotech & PharmaUpdate note
Hanmi Pharm Q3 2026 Preliminary Results: Operating Profit Falls 31.3% Year on Year
Hanmi Pharm's preliminary Q3 2026 results show revenue up 4.2% but operating profit down 31.3% from a year earlier, and down 71.2% from Q2. The result interrupts the margin-improvement story in the previous report, and our model estimate sits well below the current share price.
Oct 27, 20260 views
Aton158430· SoftwareInitiation
Aton: Steady Revenue and High Margins, but Thin Net Profit and Negative Free Cash Flow
Aton, a KOSDAQ software company, has a market cap of about ₩121.3B and a share price of ₩4,955, down 31.0% over one year but up 24.8% over three months. Operating margins remain solid at 16.2%, while net income, return on equity and free cash flow are weak.
Oct 27, 20260 views
Temc425040· ChemicalsInitiation
Temc: Shares Up 51.0% in Three Months While Model Estimate Sits Well Below Price
Temc, a KOSDAQ-listed chemicals company with a market value of about ₩288.1B, has risen 51.0% over three months to ₩13,140, still well below its 52-week high of ₩30,300. A valuation model estimate based on the assumptions shown is ₩5,264 per share, far under the current price, while earnings have been lower than in 2022.
Oct 27, 20260 views
Shinhan Financial Group055550· Holding companiesUpdate note
Shinhan Financial Group Reports Q3 2026 Preliminary Results: Sales Nearly Double, Operating Profit Slightly Lower
Shinhan's preliminary consolidated Q3 2026 results show sales of ₩18.6T, up 95.9% from a year earlier, while operating profit of ₩1.9T was down 2.4%. Net income rose 10.9%, so the headline sales jump did not carry through to operating profit, and the underlying earnings trend is little changed.
Oct 27, 20260 views
Tongyang001520· Building materialsInitiation
Tongyang: Sharp Share Price Decline as Operating Losses Persist and Sales Shrink
Tongyang's shares closed at ₩993 on 2026-10-26, down 49.5% over one year, while trailing revenue of ₩582.1B came with an operating loss of ₩23.5B. A model estimate of ₩323 per share sits well below the current price, with a very wide bear-to-bull range.
Oct 27, 20260 views
Mirae Asset Venture Investment100790· FinancialsInitiation
Mirae Asset Venture Investment: Sharp Price Swings and Improving Earnings, With a Model Estimate Far Below the Share Price
The shares closed at ₩13,100 on 2026-10-26, down 26.4% over one month but up 75.4% over one year, against a 52-week range of ₩7,570 to ₩70,700. Trailing earnings have improved sharply, yet the valuation model's base estimate of ₩4,056 per share sits well below the market price.
Oct 27, 20260 views
RFHIC218410· ElectronicsUpdate note
RFHIC Q3 2026 Preliminary Results: Operating Profit Nearly Triples Year on Year
RFHIC reported preliminary Q3 2026 consolidated operating profit of ₩21.7B, up 194.3% from a year earlier, on revenue of ₩71.1B. The result supports the earnings recovery in our earlier report, while the model still has no fair value estimate for this company.
Oct 27, 20260 views
Gabia079940· SoftwareUpdate note
Gabia: Model fair value estimate cut about 35% after a model re-run
The model estimate of Gabia's base fair value fell 35% to ₩27,905 per share from ₩42,922 in the initiation report. The base estimate now sits below the current share price, which reverses the position described in the previous report.
Oct 27, 20260 views
Curiox Biosystems445680· Medical & precision devicesUpdate note
Curiox Biosystems: Shares Fall 15.3% in Five Days on Heavy Volume, No Filing Explains the Move
Curiox Biosystems shares fell 15.3% over five trading days to ₩58,700 on 3.0 times normal volume, partly reversing the prior week's rise. Nothing in the data explains the drop, and the business fundamentals are unchanged.
Oct 27, 20260 views
ISC095340· Retail & TradeUpdate note
ISC Q3 Preliminary Results: Operating Profit Up 25.4% Year on Year to ₩21.8B
ISC reported preliminary Q3 2026 consolidated operating profit of ₩21.8B, up 25.4% from a year earlier, while net income fell 8.2%. The result supports the operating recovery described in the previous report, but the model estimate remains well below the current share price.
Oct 27, 20260 views
Daewoo Engineering & Construction047040· ConstructionUpdate note
Daewoo E&C Q3 2026 Preliminary Results: Operating Profit Rises to ₩183.2B From ₩56.6B
Daewoo E&C reported preliminary Q3 2026 consolidated operating profit of ₩183.2B, up 223.7% from a year earlier, with revenue down 7.4%. This runs against the loss-making picture in our earlier report, but the quarter's profit is lower than Q2 and the full picture is not yet clear.
Oct 27, 20260 views
Spigen Korea192440· Consumer goodsInitiation
Spigen Korea: Low Multiples, Recovering Margins and a Share Cancellation Plan
Spigen Korea trades at ₩27,000 with a market value of about ₩167.8B, at 3.2x trailing earnings and 0.3x book value. Margins have recovered over the past twelve months, while the shares fell 9.8% in the last month and a share cancellation was announced on October 20, 2026.
Oct 27, 20260 views
Mcnex097520· ElectronicsUpdate note
Mcnex Decides to Cancel 901,500 Treasury Shares, Cutting Issued Shares by 5.2%
Mcnex's board decided on Oct 21, 2026 to cancel 901,500 treasury shares, about 5.2% of issued shares, with cancellation planned for Oct 30. This reduces the share count but does not change the earnings picture in the previous report, and the model estimate base case now sits above the share price.
Oct 26, 20260 views
Emro058970· SoftwareInitiation
Emro: Revenue Growth Slows as Profits Fade and the Share Price Falls 67.2% in a Year
Emro, a KOSDAQ software company, closed at ₩14,290 on 2026-10-23, down 67.2% over one year, while trailing operating income turned negative at -₩3.4B. The model estimate based on the assumptions shown is below the current share price.
Oct 26, 20260 views
Alux475580· Consumer goodsInitiation
Alux: Revenue Growing but Losses Persist, Shares Down 41.7% Over One Year
Alux, a KOSDAQ consumer goods company, has grown revenue but swung from a profit in 2024 to losses in 2025 and the first half of 2026. The shares closed at ₩6,220 on 2026-10-23, 41.7% lower than a year earlier and near the lower end of the 52-week range.
Oct 26, 20260 views
Exem205100· SoftwareInitiation
Exem: Sharp Drop in Share Price Alongside Strong H1 2026 Earnings, Boosted by Net Income Well Above Operating Income
Exem, a KOSDAQ-listed software company, closed at ₩1,380 on 2026-10-23, down 36.6% over one year, with a market cap of about ₩93.2B. Trailing earnings to H1 2026 show a 13.9% operating margin and net income of ₩27.5B, far above operating income of ₩6.6B.
Oct 26, 20260 views
Dongkuk Steel Mill460860· Steel & MaterialsUpdate note
Dongkuk Steel Mill Files Value-Up Plan Targeting 0.3x Price-to-Book and 3–4% ROE by 2028
Dongkuk Steel Mill filed a corporate value-up plan on 2026-10-21 that sets targets of 0.3x price-to-book and a 3–4% return on equity by 2028. The plan adds stated goals and shareholder return commitments, but it does not change the earnings picture in our previous report.
Oct 26, 20260 views
Lotte Chilsung Beverage005300· Food & BeverageUpdate note
Lotte Chilsung Beverage: Model Fair Value Estimate Rises 20% on a Lower Discount Rate
Our model estimate of fair value for Lotte Chilsung Beverage rose 20.2% to ₩420,785 per share from ₩349,990, while the share price fell to ₩94,900. The change comes from the model's assumptions, not from new company results, so it adds little new evidence about the business.
Oct 26, 20260 views
Nano187790· ChemicalsInitiation
Nano: Shares Fall Sharply Over Three Months as Earnings Stay Thin and Cash Flow Turns Negative
Nano's shares closed at ₩2,335 on 2026-10-23, down 23.7% over one month and 24.8% over three months, though still up 35.0% over one year. Trailing profits are modest, free cash flow is negative, and the model estimate based on the assumptions shown is well below the current price.
Oct 26, 20260 views
Vuno338220· SoftwareInitiation
Vuno: Revenue Has Grown Sharply, but Losses Persist and a Rights Offering Is Under Way
Vuno's revenue has risen every year since 2021, reaching ₩34.8B in 2025, but the company remains loss-making, with a trailing operating margin of -31.9%. The share price is down 74.9% over one year, and recent filings show repeated amendments to a rights offering.
Oct 26, 20260 views
JYP Entertainment035900· EntertainmentUpdate note
JYP Entertainment jumps 18% after-hours on report of a Japanese capital acquisition attempt
JYP Entertainment shares rose 18% in after-hours trading on 2026-10-26 after a news report of a possible acquisition attempt by Japanese capital. The report is unconfirmed in the data we have, so it does not change our reading of the company's fundamentals, though our model estimate has been revised lower.
Oct 26, 20260 views
Solum248070· Electronic componentsUpdate note
Solum: Activist Align Partners Raises Stake to 23.5%
A 5%+ holding report filed on 2026-10-26 shows activist investor Align Partners Asset Management (얼라인파트너스자산운용) now holds 23.46% of Solum, up 0.22 points. The filing adds to the ownership picture but does not change the earnings data, and the model estimate remains very wide.
Oct 26, 20260 views
VT018290· ChemicalsUpdate note
VT Announces Tangible Asset Acquisition Equal to 22.4% of Total Assets
VT filed a decision to acquire tangible assets equal to 22.4% of its total assets on 2026-10-26. The filing excerpt is not available, so the price, asset type and funding are unknown, and the effect on the earnings outlook cannot yet be judged.
Oct 26, 20260 views
Industrial Bank of Korea024110· BanksUpdate note
Industrial Bank of Korea: Q3 Preliminary Results Show Flat Profit Despite 78.9% Jump in Reported Revenue
Industrial Bank of Korea reported preliminary Q3 2026 consolidated results: operating profit of ₩1.0T (up 5.6% y/y) and net income of ₩771.2B (up 2.7% y/y), while nine-month net income is down 2.0%. The headline revenue surge does not translate into profit growth, so the earnings picture stays broadly in line with the earlier report's flat-profit thesis.
Oct 26, 20260 views
The Pinkfong403850· EntertainmentInitiation
The Pinkfong Company: Low Multiples, Large Cash Balance and a Share Cancellation, After a Steep Fall From Its Highs
The Pinkfong Company trades at ₩11,920 per share and a market cap of ₩171.1B, far below its 52-week high of ₩61,500. Filings show a net cash balance sheet and low multiples, but TTM net income is boosted well above operating income and revenue has been flat to slightly lower.
Oct 26, 20260 views
NH Investment & Securities005940· FinancialsUpdate note
NH Investment & Securities: Q3 Preliminary Operating Profit Up 33.2% Year on Year, Down 23.5% From Q2
NH Investment & Securities reported preliminary Q3 2026 consolidated operating profit of ₩521.1B, up 33.2% from a year earlier but down 23.5% from the prior quarter. The year-on-year growth supports the earnings trend in our earlier report, while the quarterly step-down shows that the H1 pace was not repeated.
Oct 26, 20260 views
kt alpha036030· Retail & TradeInitiation
kt alpha: Profits Recovered Since 2024 While Shares Trade Below Book Value
kt alpha, a KOSDAQ-listed retail and trade company, earned ₩43.7B in net income over the twelve months to H1 2026 on ₩391.8B of revenue, and its shares closed at ₩4,770 on 2026-10-23. The shares trade at 5.4x earnings and 0.8x book value, below a model estimate of ₩8,183 per share based on the assumptions shown.
Oct 26, 20260 views
Huons Global084110· Biotech & PharmaUpdate note
Huons Global: Model Fair Value Estimate Rises 34.3% on Lower Discount Rate
Our model estimate of fair value for Huons Global rose to a base of ₩75,025 per share from ₩55,862, mainly reflecting a lower discount rate of 6.5% versus 7.5%. The shares closed at ₩22,200, still below even the new bear case of ₩21,544 only marginally, so the market price remains far from the model's assumptions.
Oct 26, 20260 views
Tonymoly214420· CosmeticsInitiation
Tonymoly: Shares Down 51.3% Over a Year While Trailing Profit Stays Positive
Tonymoly's shares closed at ₩4,515 on 2026-10-23, down 51.3% over one year, with a market value of about ₩108.6B. Trailing revenue of ₩214.8B and net income of ₩11.3B point to a business that has moved from losses in 2021-2022 to modest profits.
Oct 26, 20260 views
IT'S Hanbul226320· CosmeticsInitiation
IT'S Hanbul: Profits Recover While Shares Trade Above a Model Estimate
IT'S Hanbul's trailing revenue reached ₩172.2B with a 13.9% operating margin, a sharp improvement from losses in 2021 and 2022. The share price of ₩10,920 sits well above the valuation model's base estimate of ₩6,803 per share, even though the stock trades at 0.6x book value.
Oct 26, 20260 views
Asiana Airlines020560· AirlinesUpdate note
Asiana Airlines Wins Dismissal of US Damages Lawsuit Seeking Over ₩2T
Asiana Airlines reported that a US damages lawsuit seeking more than ₩2T was dismissed, with compensation of ₩0. This removes one legal unknown flagged in the previous report, but it does not change the weak earnings and thin equity picture.
Oct 26, 20260 views
JW Pharmaceutical001060· Biotech & PharmaUpdate note
JW Pharmaceutical: Model Fair Value Estimate Rises to ₩52,434 Base Case as Shares Slip to ₩23,900
Our valuation model's base estimate for JW Pharmaceutical rose to ₩52,434 per share from ₩42,784, while the share price fell to ₩23,900. The change comes from the model inputs, not from a new company filing, so it adjusts the valuation picture but not the underlying business facts.
Oct 25, 20260 views
DuChemBio176750· Biotech & PharmaUpdate note
DuChemBio: Model Fair Value Estimate Cut 24.4% to ₩4,009 per Share
Our model estimate of DuChemBio's fair value fell to ₩4,009 per share from ₩5,300 in the previous report. The shares still trade well above it, so the gap between price and model estimate remains wide.
Oct 25, 20260 views
Graphy318060· ChemicalsUpdate note
Graphy shares fall 17.4% in five trading days on heavy volume
Graphy's shares dropped 17.4% over five trading days to 2026-10-20 on 2.1× normal volume, extending the slide described in our initiation report. The move deepens the market's caution, but the data gives no cause and does not change the fundamental picture.
Oct 25, 20260 views
Purit445180· ChemicalsUpdate note
Purit: Model Fair Value Estimate Cut by About 25% With No New Filing Behind It
Our model estimate of Purit's fair value fell about 25% to ₩15,956 per share from ₩21,323, while the share price closed at ₩7,930 on 2026-10-23. The change does not appear to come from new company filings, so it mainly lowers the estimate the previous report relied on.
Oct 25, 20260 views
Hannong Chemicals011500· CosmeticsInitiation
Hannong Chemicals: Profits Recovering From a Low Base, While the Model Estimate Sits Far Below the Share Price
Hannong Chemicals' trailing operating margin rose to 5.4% in H1 2026 from 1.7% in 2025, but free cash flow is negative and the stock is down 16.6% over one year. The valuation model's base estimate of ₩1,937 per share is well below the ₩12,730 close.
Oct 25, 20260 views
Kyungdong City Gas267290· UtilitiesInitiation
Kyungdong City Gas: Thin Margins, Low Multiples and a Wide Range of Model Estimates
Kyungdong City Gas trades at ₩20,700 with a market cap of about ₩122.0B, a P/E of 3.3 and a P/B of 0.2. Revenue is large relative to the company's size, but operating margins are only 2.3% and no dividend yield is shown.
Oct 25, 20260 views
Hankook Cosmetics123690· Retail & TradeInitiation
Hankook Cosmetics: Profits Have Faded While the Share Price Has Fallen Sharply Over the Past Year
Hankook Cosmetics closed at ₩5,600 on 2026-10-23, down 44.4% over one year, with a market value of about ₩90.0B. Revenue is around ₩81.9B over the trailing twelve months, but operating margin is just 0.7% and the model estimate is below the current price.
Oct 25, 20260 views
Huons243070· Biotech & PharmaUpdate note
Huons: Model Fair Value Estimate Cut to ₩51,504 Base Case as Discount Rate Edges Lower and Bear Case Falls Sharply
Our model estimate of fair value for Huons moved sharply lower, with the base case now at ₩51,504 per share versus ₩76,573 in the previous report. The estimate is still far above the ₩17,370 share price, but the range has become much wider on the downside.
Oct 25, 20260 views
Muhak033920· Food & BeverageInitiation
Muhak: Low Book Multiple and High Yield Sit Beside Thinner Operating Margins and a Model Estimate Below the Share Price
Muhak closed at ₩7,170 on 2026-10-23, down 15.1% over one year and close to its 52-week low of ₩7,080, with a market value of about ₩204.3B. Trailing operating margin has fallen to 4.4% from 11.1% in 2024, while net income is far larger than operating income.
Oct 25, 20260 views
Seers458870· Medical & precision devicesUpdate note
Seers: ₩110B Convertible Bond Fundraising Completed, Overseas Investment Phase Begins
A news report on October 21 says the company completed its ₩110B fundraising, and a filing the same day reports the results of the 2nd series convertible bond issue. This turns the plan in our October 18 initiation into a completed financing, while the model still has no estimate for the company.
Oct 25, 20260 views
Handsome020000· Textiles & ApparelInitiation
Handsome: Low Multiples and Thinner Margins as Share Cancellation and Holding Filings Stack Up
Handsome's shares closed at ₩18,600 on 2026-10-23, up 24.2% over one year but down 9.7% over three months, with profit margins well below their 2021–2022 levels. The valuation model's base estimate is above the share price, but the range between bear and bull cases is very wide.
Oct 25, 20260 views
Heungkuk Fire & Marine Insurance000540· InsuranceInitiation
Heungkuk Fire & Marine: Low Multiples and a 16.9% One-Year Share Price Decline, With Several Data Gaps
Heungkuk Fire & Marine closed at ₩3,195 on 2026-10-23, down 16.9% over one year and well below its 52-week high of ₩7,480. The trailing P/E is 1.2, far below the listed peers shown, but several key figures, including revenue, book value multiple and the valuation model estimate, are not available.
Oct 25, 20260 views
Gaeasoft051160· SoftwareInitiation
Gaeasoft: Sharp Share Price Rise, Thin Margins and a Model Estimate Well Above the Market Price
Gaeasoft's shares closed at ₩12,700 on 2026-10-23, up 70.2% over three months, while trailing operating margin stays thin at 5.5%. A model estimate of ₩30,556 per share sits well above the price, but it rests on assumptions and a wide bear-to-bull range.
Oct 25, 20260 views
Celemics331920· Biotech & PharmaInitiation
Celemics: Loss-making KOSDAQ biotech with a sharp one-year share price rise and a model estimate far below the market price
Celemics shares closed at ₩9,670 on 2026-10-23, up 223.4% over one year but down 14.8% over one month, while the company reported a trailing operating loss of ₩3.9B on revenue of ₩5.2B. The valuation model's base estimate of ₩858 per share sits well below the current price, and the filings show a recent rights offering decision.
Oct 25, 20260 views
IL307180· Electrical equipmentInitiation
IL: Revenue Has Grown but Losses Persist While the Share Price Has Nearly Doubled Over a Year
IL, a KOSDAQ-listed electrical equipment company with a market value of about ₩193.4B, posted trailing revenue of ₩98.6B but an operating loss of ₩5.2B. The shares are up 90.5% over one year yet down 9.3% over the past month.
Oct 25, 20260 views
DreamCIS223250· Biotech & PharmaInitiation
DreamCIS: Strong Share Price Rebound Meets Sharply Lower Trailing Profit
DreamCIS shares closed at ₩4,165 on 2026-10-23, up 26.6% in one month and 45.1% in three months but still 15.6% lower over one year. Trailing revenue is ₩73.3B, while trailing net income fell to ₩329M, leaving the trailing P/E at 311.6.
Oct 25, 20260 views
Osteonic226400· Medical & precision devicesInitiation
Osteonic: Profitable Growth and Low Multiples Alongside a 44.6% One-Year Share Price Decline
Osteonic's filed results show revenue rising every year since 2021 and an operating margin of 18.4% over the twelve months to H1 2026, while the share price is down 44.6% over one year to ₩4,170. A model estimate based on the assumptions shown sits above the current price in the base case, but the bear case sits below it.
Oct 24, 20260 views
Vieworks100120· Medical & precision devicesInitiation
Vieworks: Earnings Recovery in H1 2026 Meets a Share Price Near Book Value
Vieworks, a KOSDAQ-listed medical and precision devices company, shows trailing operating margin of 13.3% and ROE of 17.5% through H1 2026, up from 8.9% and 9.0% in 2025. The shares closed at ₩27,750, below the model's base estimate of ₩36,652, after rising 38.9% over one year.
Oct 24, 20260 views
Robostar090360· MachineryInitiation
Robostar: Share Price Far Above a Model Estimate as Earnings Stay Near Breakeven
Robostar's shares closed at ₩58,800 on 2026-10-23, down 25.6% over one month, with a market value of ₩573.3B. Trailing revenue is ₩93.4B with a small operating loss, and the model estimate of ₩2,972 per share is far below the market price.
Oct 24, 20260 views
Samsung Electronics005930· ElectronicsUpdate note
Samsung Electronics: News Flags Confirmed Q3 Results This Week, With Operating Profit Forecast at ₩185T
A Yonhap News Agency report says confirmed Q3 earnings are due this week and that HBM4 could push operating profit to ₩185T. This is a press forecast, not a filing, and it sits well above the preliminary ₩107.4T in the previous report, so the numbers need checking when the confirmed figures arrive.
Oct 24, 20260 views
Curocell372320· Biotech & PharmaInitiation
Curocell: Pre-revenue biotech with widening losses and a share price down 40.3% over one year
Curocell is a KOSDAQ-listed biotech with a market value of about ₩352.5B and no reported revenue in 2023, 2024, 2025 or the first half of 2026. Losses have continued, the share price is 65.0% below its 52-week high, and the model estimate is not available.
Oct 24, 20260 views